The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
NCT06601010
·
clinicaltrials.gov ↗
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Sponsor
Ruijin Hospital